At Access, Delivered, our research team is dedicated to advancing knowledge and improving practices in medication abortion and telehealth services. Through rigorous, peer-reviewed studies, we provide valuable insights that drive innovation and inform best practices in the field. Our research underscores the transformative potential of telehealth and medication abortion in expanding access to abortion care and supports the integration of these services into primary care settings. These findings play a crucial role in expanding access to care.
Below, you’ll find a selection of our published research that highlights our contributions and the evidence supporting our approach.
Our research has demonstrated that:
- Requests for medication abortion telehealth doubled in the months following Dobbs, particularly among people living farthest from in-person clinics (JAMA Network Open, October 2025) link
- Asynchronous telehealth abortion patients require minimal communication, and most inquiries can be addressed by nonclinical staff (Contraception, October 2025) link
- Demand for telehealth medication abortion increased after the Dobbs decision in states where abortion remained legal (Women’s Health Issues, September 2025) link
- Advance-provision patients differ from pregnant patients and do not represent the demographics of those who traditionally have limited access to abortion care (Obstetrics & Gynecology, May 2025) link
- More people are traveling from out of state for abortion care after Dobbs, delaying in-state patient care (JAMA Network Open, May 2024) link
- Telehealth abortion in primary care is timelier and more accessible than in-clinic services when mifepristone regulations are enforced (The Journal of the American Board of Family Medicine, March 2024) link
- Patients appreciate the integration of telehealth abortion care into their established primary care settings for reducing barriers and normalizing abortion (Annals of Family Medicine, February 2024) link
- Advance provision of abortion medications was positively received by participants, who valued the increased timeliness and convenience of having medications on hand (Contraception, July 2023) link
- Telehealth is reaching some communities traditionally underserved by abortion services (Contraception, May 2023) link
- Telemedicine medication abortion was associated with higher patient-reported satisfaction in communication compared to traditional in-clinic visits (Obstetrics and Gynecology, June 2023) link
- Telehealth abortion services can be seamlessly integrated into various clinical practices (Annals of Family Medicine, July 2022) link
- One clinician can serve patients requesting online abortion services across an entire state (Contraception, March 2021) link
- Primary care clinicians in the U.S. can safely and effectively offer telehealth medication abortion services (Contraception, February 2021) link
We have presented our work at a variety of conferences across diverse fields in healthcare and public health